Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 22% ± 3% | |
| fibroblast | 6 studies | 22% ± 4% | |
| microglial cell | 6 studies | 23% ± 8% | |
| pericyte | 4 studies | 23% ± 7% | |
| basal cell | 4 studies | 20% ± 3% | |
| epithelial cell | 3 studies | 36% ± 7% | |
| connective tissue cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2495.82 | 1445 / 1445 | 99% | 31.16 | 182 / 183 |
| stomach | 100% | 1624.01 | 359 / 359 | 98% | 22.09 | 280 / 286 |
| intestine | 100% | 1866.20 | 966 / 966 | 98% | 20.46 | 515 / 527 |
| lung | 100% | 3153.62 | 578 / 578 | 97% | 24.99 | 1126 / 1155 |
| breast | 100% | 2505.81 | 459 / 459 | 95% | 36.67 | 1061 / 1118 |
| pancreas | 99% | 1380.88 | 326 / 328 | 95% | 25.40 | 169 / 178 |
| bladder | 100% | 2381.81 | 21 / 21 | 94% | 23.84 | 475 / 504 |
| skin | 100% | 3171.32 | 1808 / 1809 | 93% | 22.90 | 441 / 472 |
| prostate | 100% | 2248.36 | 245 / 245 | 93% | 20.78 | 468 / 502 |
| uterus | 100% | 2281.34 | 170 / 170 | 91% | 20.63 | 419 / 459 |
| kidney | 98% | 1045.45 | 87 / 89 | 88% | 18.18 | 794 / 901 |
| thymus | 100% | 1682.54 | 652 / 653 | 84% | 15.69 | 506 / 605 |
| ovary | 100% | 1960.83 | 180 / 180 | 77% | 9.30 | 332 / 430 |
| adrenal gland | 100% | 2080.66 | 258 / 258 | 54% | 7.32 | 125 / 230 |
| liver | 85% | 621.96 | 192 / 226 | 48% | 5.54 | 195 / 406 |
| brain | 34% | 191.44 | 887 / 2642 | 70% | 7.64 | 492 / 705 |
| adipose | 100% | 2801.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2940.37 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 992.14 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.14 | 1 / 1 |
| heart | 96% | 1136.98 | 830 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 22.98 | 42 / 45 |
| muscle | 92% | 691.69 | 741 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 80% | 11.90 | 64 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 55% | 7.93 | 16 / 29 |
| peripheral blood | 31% | 231.28 | 292 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016020 | Cellular component | membrane |
| Gene name | ITPRIPL2 |
| Protein name | Alternative protein ITPRIPL2 Inositol 1,4,5-trisphosphate receptor-interacting protein-like 2 |
| Synonyms | |
| Description | |
| Accessions | ENST00000381440.5 L8EC69 Q3MIP1 |